NCT06777823 is a NA clinical trial of Social Rejection Task in Rejection Sensitivity, sponsored by Washington University School of Medicine.

Who is sponsoring NCT06777823?

NCT06777823 is sponsored by Washington University School of Medicine.

What drugs are being tested in NCT06777823?

Interventions in NCT06777823: Social Rejection Task.

What condition does NCT06777823 study?

NCT06777823 studies Rejection Sensitivity, Puberty, Psychopathology.

Is NCT06777823 still recruiting?

NCT06777823 is currently recruiting now. Last updated 11 May 2025.

Last reviewed 2025-05-11 · How we verify

NCT06777823

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls

Recruiting now NA Last updated 11 May 2025

What this trial tests

NA trial testing Social Rejection Task in Rejection Sensitivity in 250 participants. Currently enrolling.

Timeline

5 February 2025

Primary endpoint
1 June 2028

30 June 2029

Quick facts

Lead sponsor	Washington University School of Medicine
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	250
Start date	5 February 2025
Primary completion	1 June 2028
Estimated completion	30 June 2029
Sites	1 location across United States

Drugs / interventions tested

Social Rejection Task

Conditions studied

Rejection Sensitivity — all drugs for Rejection Sensitivity →
Puberty — all drugs for Puberty →
Psychopathology — all drugs for Psychopathology →

Sponsor

Washington University School of Medicine

Who can join

10 and older, female only, with Rejection Sensitivity or Puberty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This longitudinal study is designed to test bidirectional relationships between preteen girls' mental health and social media experiences. We will explore how pubertal development and experiences of rejection influence these relationships.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Washington University School of Medicine trials

Trials by the same sponsor.

NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06777823 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
Last refreshed: 11 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06777823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing